Form 8-K HEAT BIOLOGICS, INC. For: May 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Heat Biologics (HTBX) Misses Q1 EPS by 8c
May 14, 2015 9:28 AM EDTHeat Biologics (NASDAQ: HTBX) reported Q1 EPS of ($0.57), $0.08 worse than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Heat Biologics (HTBX) click here.
... More